Gene therapies to treat rheumatoid arthritis have evolved slowly, but one is ready to move into human trials and an ...

CRISPR Therapeutics is a mid-stage biotech specializing in gene editing. It became the first gene-editing treatment that uses the Nobel Prize-winning CRISPR technique, an impressive achievement by ...

Vertex and CRISPR Therapeutics ... can also access this treatment as soon as possible. It involves harvesting bone marrow stem cells from patients and using CRISPR/Cas9 to modify them outside ...

Reni-cel treatment involves an ex vivo use of gene-editing – where the technology is used to modify a patient's own cells outside the body – and is playing catch-up with Vertex and CRISPR ...

Jan. 27, 2025 — The world's botanic gardens must pull together to protect global plant biodiversity in the face of the extinction crisis, amid restrictions on wild-collecting, say ...

How much is Crispr Therapeutics Ag stock worth? Invest with precise valuations. Get Report.

Danielle is an Assistant Editor at The Scientist. She has a background in neuroscience and molecular psychiatry. She has previously written for BioTechniques News, The Scientist, and Drug Discovery ...

Genetic alterations may help mosquitoes adjust to climate change, shifting the distribution of mosquito-borne disease in a warming planet.

These are known as disease-modifying treatments and have been licensed for private use. Other medications are under review to see if they could be prescribed to people in the very early stages of ...

The logo of Stellantis is seen on the company's building in Poissy, near Paris, France, September 4, 2024. REUTERS/Sarah Meyssonnier/File Photo Stellantis announced management changes on Monday as ...